Aon plc (AON) announced a strategic investment in eMed Population Health, an emerging leader in the delivery of GLP-1 programs. The partnership will enhance employer sponsored access to GLP-1 therapies and scale solutions for obesity. The investment follows the launch earlier this year of Aon’s subsidized GLP-1 weight management benefit program for its U.S. workforce – developed by eMed – which has delivered strong adherence, high retention and sustainable results for the firm’s colleagues. In the sixth months since Aon’s program launched, more than 1,200 people have registered and the firm has seen an average of 22.4 pounds lost with a retention rate of 95%. With this investment, eMed will continue to increase distribution of its digital-first healthcare platform – which combines at-home diagnostics, proctor-led screenings, clinician-guided prescribing, and continuous adherence support-to reach more employers and patients.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AON:
- Deere, Cisco dip after quarterly reports: Morning Buzz
- Aon sued for alleged fraud linked to credit insurance for start-ups, FT reports
- C3 AI downgraded, Capri upgraded: Wall Street’s top analyst calls
- Aon plc initiated with a Neutral at Citi
- Cantor rolls out P&C insurance coverage, sees ‘market in transition’